Wei Wang

Dr. Wei Wang

orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 June 2023 in EBioMedicine
Verified
Journal Article
Open access
JDJianye Deng
Jianye Deng
HZHong-Jin Zhao
Hong-Jin Zhao
YZYing Zhong
Ying Zhong
CHCuiping Hu
Cuiping Hu
JMJinlai Meng
Jinlai Meng
YLYan Li
Yan Li
Preeclampsia (PE) is a common hypertensive pregnancy disorder associated with shallow trophoblast invasion. Although bone morphogenetic protein 2 (BMP2) has been shown to promote trophoblast invasion in vitro, its cellular origin and molecular regulation in placenta, as well as its potential role in PE, has yet to be established. Additionally, whether BMP2 and/or its downstream molecules could serve as potential diagnostic or therapeutic targets for PE has not been explored. Placentas and sera from PE and healthy pregnant women were subjected to multi-omics analyses, immunoblots, qPCR, and ELISA assays. Immortalized trophoblast cells, primary cultures of human trophoblasts, and first-trimester villous explants were used for in vitro experiments. Adenovirus expressing sFlt-1 (Ad Flt1)-induced PE rat model was used for in vivo studies. We find globally decreased H3K27me3 modifications and increased BMP2 signalling in preeclamptic placentas, which is negatively correlated with clinical manifestations. BMP2 is derived from Hofbauer cells and epigenetically regulated by H3K27me3 modification. BMP2 promotes trophoblast invasion and vascular mimicry by upregulating BMP6 via BMPR1A-SMAD2/3-SMAD4 signalling. BMP2 supplementation alleviates high blood pressure and fetal growth restriction phenotypes in Ad Flt1-induced rat PE model. Our findings demonstrate that epigenetically regulated Hofbauer cell-derived BMP2 signalling enhancement in late gestation could serve as a compensatory response for shallow trophoblast invasion in PE, suggesting opportunities for diagnostic marker and therapeutic target applications in PE clinical management. National Key Research and Development Program of China (2022YFC2702400), National Natural Science Foundation of China (82101784, 82171648, 31988101), and Natural Science Foundation of Shandong Province (ZR2020QH051, ZR2020MH039).

24 February 2023 in Journal of Allergy and Clinical Immunology
Verified
Journal Article
Closed access
WWWei Wang
Wei Wang
CGCarolyn Garcia
Carolyn Garcia
FSFengzhi Shao
Fengzhi Shao
JCJonathan A. Cohen
Jonathan A. Cohen
YBYan Bai
Yan Bai
XAXingbin Ai
Xingbin Ai

14 August 2021 in STAR Protocols
Verified
Journal Article
Open access
WWWei Wang
Wei Wang
XAXingbin Ai
Xingbin Ai
Primary T-cell culture is an invaluable model for investigating mechanisms underlying T-cell differentiation and function in health and disease. However, different culture conditions are required for immature versus mature CD4+ T cells. Here, we provide an improved culture protocol for immature naïve mouse CD4+ T cells, including details for splenocyte isolation, naïve CD4+ T-cell purification and differentiation, and functional evaluation via flow cytometry. This protocol can also be applied for immature human CD4+ T cells.

2 May 2022
Verified
Conference Paper
Closed access
ADA.A. Diaz
A.A. Diaz
SGS. Grumley
S. Grumley
HNH.P. Nath
H.P. Nath
WWWei Wang
Wei Wang
AYA.C. Yen
A.C. Yen
RER. San Jose Estepar
R. San Jose Estepar